Sign In
Buy DCPH
$25.59
+0 (+0%)
At Close: Sep 09, 2024
ONO to buy Deciphera Pharmaceuticals at a huge premium
11:19am, Monday, 29'th Apr 2024
Deciphera Pharmaceuticals Inc (NASDAQ: DCPH) is up a whopping 75% today after ONO Pharmaceutical (TYO: 4528) announced plans of buying it for $2.4 billion. Deciphera Pharmaceuticals stock valued at
Why Is Deciphera Pharmaceuticals (DCPH) Stock Up 72% Today?
10:33am, Monday, 29'th Apr 2024
Deciphera Pharmaceuticals (NASDAQ: DCPH ) stock is rising higher on Monday after signing a $2.4 billion acquisition agreement with ONO Pharmaceutical. This deal has ONO Pharmaceutical acquiring Deciph
MILWAUKEE , April 29, 2024 /PRNewswire/ -- Ademi LLP is investigating Deciphera (NASDAQ: DCPH) for possible breaches of fiduciary duty and other violations of law in its transaction with ONO. Click h
Deciphera Catapults 72% After Ono Pharmaceutical Agrees To Buy It For $2.4 Billion
09:19am, Monday, 29'th Apr 2024
Deciphera stock rocketed to a three-year high Monday after Ono Pharmaceutical agreed to buy it for $2.4 billion.
Deciphera Pharmaceuticals Is Being Acquired and the Stock Soars 71%
09:01am, Monday, 29'th Apr 2024
Deciphera Pharmaceuticals is being bought by Japan's ONO Pharmaceutical in a deal valued at $2.4 billion.
DCPH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Deciphera Pharmaceuticals, Inc. Is Fair to Shareholders
08:44am, Monday, 29'th Apr 2024
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) to ONO Pharmaceutical Co., Ltd. for $25.60
Deciphera to be acquired by Japan's Ono in all-cash deal valued at $2.4 billion
07:24am, Monday, 29'th Apr 2024
Deciphera Pharmaceuticals Inc. DCPH, +3.31% said Monday it has agreed to be acquired by Japan's Ono Pharmaceutical Co. Ltd 4528, +1.34% in an all-cash deal valued at $2.4 billion. Under the terms of t
Japan's ONO Pharmaceutical to buy Deciphera for $2.4 billion
07:08am, Monday, 29'th Apr 2024
Deciphera Pharmaceuticals said on Monday Japan's ONO Pharmaceutical Co will acquire the company for $2.4 billion in cash.
Deciphera Pharmaceuticals to be Acquired by ONO Pharmaceutical For $2.4 Billion
07:00am, Monday, 29'th Apr 2024
WALTHAM, Mass.--(BUSINESS WIRE)--Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve
Deciphera Pharmaceuticals, Inc. (DCPH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
11:07am, Wednesday, 24'th Apr 2024
Deciphera Pharmaceuticals (DCPH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH)
08:45am, Thursday, 18'th Apr 2024
NEW YORK , April 18, 2024 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) on behalf of the company's shareholders. The inv
Deciphera Pharmaceuticals to Present at the Stifel 2024 Virtual Targeted Oncology Forum
07:00am, Tuesday, 09'th Apr 2024
WALTHAM, Mass.--(BUSINESS WIRE)--Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve
Why Is Deciphera Pharmaceuticals, Inc. (DCPH) Up 20.8% Since Last Earnings Report?
12:36pm, Thursday, 07'th Mar 2024
Deciphera Pharmaceuticals, Inc. (DCPH) reported earnings 30 days ago. What's next for the stock?
Wall Street Analysts Think Deciphera Pharmaceuticals, Inc. (DCPH) Could Surge 48.49%: Read This Before Placing a Bet
10:56am, Wednesday, 28'th Feb 2024
The consensus price target hints at a 48.5% upside potential for Deciphera Pharmaceuticals, Inc. (DCPH). While empirical research shows that this sought-after metric is hardly effective, an upward tre
Wall Street Analysts Believe Deciphera Pharmaceuticals, Inc. (DCPH) Could Rally 59.63%: Here's is How to Trade
10:56am, Monday, 12'th Feb 2024
The average of price targets set by Wall Street analysts indicates a potential upside of 59.6% in Deciphera Pharmaceuticals, Inc. (DCPH). While the effectiveness of this highly sought-after metric is
